Top

Indian Journal of Hematology and Blood Transfusion

Published in:

01-06-2016 | Case Report

Chronic Myeloid Leukemia with Extramedullary Blast Crisis: Two Unusual Sites with Review of Literature

Authors: Kamal Kant Sahu, Pankaj Malhotra, Preithy Uthamalingam, Gaurav Prakash, Amanjit Bal, Neelam Varma, Subhash Chandar Varma

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Abstract

Extramedullary blast crisis (EBC) in chronic myeloid leukemia (CML) is a rare phenomenon and represents infiltration of leukemic blasts in areas other than bone marrow. Lymph node is the most common site of involvement by EBC. We herein present a case of CML who suffered from two discrete episodes of EBC at atypical locations (scalp and paravertebral) within an interval duration of nine months. A-38-year-old female was diagnosed as a case of CML with extramedullary blast crisis in scalp at presentation. She received treatment with imatinib 600 mg once daily through Novartis Oncology Access Program (NOA). She achieved hematological remission. However nine months later she was readmitted with spinal shock due to cord compression secondary to paraspinal chloroma. She was started on tablet Nilotinib in view of failure to 1st line therapy. Her compressive myelopathy was treated with pulses of high dose dexamethasone. However soon she died due to pneumonia.

Cervantes F, Rozman M, Nicolas JM, Lopez GA, Rozman C (1989) [Extramedullary blast crisis in chronic myeloid leukemia]. Sangre 34(2):96–98 Epub 1989/04/01PubMed

Apfelbeck U, Hoefler G, Neumeister P, Fonatsch C, Linkesch W, Sill H (2000) Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation. Bone Marrow Transpl 26(10):1111–1112CrossRef

Karbasian Esfahani M, Morris EL, Dutcher JP, Wiernik PH (2006) Blastic phase of chronic myelogenous leukemia. Curr Treat Options Oncol 7(3):189–199CrossRefPubMed

Jacob A, Rowlands DC, Patton N, Holmes JA (1994) Chronic granulocytic leukaemia presenting with an extramedullary T lymphoblastic crisis. Br J Haematol 88(2):435–436CrossRefPubMed

Gonzalez FA, Villegas A, Ferro MT, Cabello P, Morales D, Perez J et al (1993) Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia. Br J Haematol 84(2):351–352CrossRefPubMed

Inverardi D, Lazzarino M, Morra E, Bernasconi P, Merante S, Canevari A et al (1990) Extramedullary disease in Ph’-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance. Haematologica 75(2):146–148PubMed

Specchia G, Palumbo G, Pastore D, Mininni D, Mestice A, Liso V (1996) Extramedullary blast crisis in chronic myeloid leukemia. Leuk Res 20(11–12):905–908CrossRefPubMed

O’Brien S, Witt R, Talpaz M, Kantarjian H (1991) Extramedullary blast crisis in a patient with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic remission. Cancer 67(7):1946–1949CrossRefPubMed

Sun T, Susin M, Koduru P, Coffey EL Jr, Dittmar K, Weiss R et al (1991) Extramedullary blast crisis in chronic myelogenous leukemia. Demonstration of T-cell lineage and Philadelphia chromosome in a paraspinal tumor. Cancer 68(3):605–610 Epub 1991/08/01CrossRefPubMed

10.

Kell J, Booth M, Jones B, Appleton M, Lim S (1998) Extramedullary T lymphoblastic transformation of chronic myeloid leukaemia occurring after double allogeneic transplantation. Bone Marrow Transpl 22(8):813–816CrossRef

11.

Van Dorpe J, Van Damme S, Jacobs V, Van den Berghe H, Criel A, Michielssen P et al (1995) T-lymphoid extramedullary (lymphadenopathic) blast crisis in CML. Acta Clin Belg 50(2):121–125CrossRefPubMed

12.

Advani SH, Malhotra H, Kadam PR, Iyer RS, Nanjangud G, Balsara B et al (1991) T-lymphoid blast crisis in chronic myeloid leukemia. Am J Hematol 36(2):86–92CrossRefPubMed

13.

Tassies D, Feliu E, Villamor N, Urbano-Ispizua A, Cervantes F, Campo E et al (1990) T lymphoblastic leukemia with leukemoid reaction or the extramedullary blast crisis of Philadelphia chromosome-negative chronic myeloid leukemia. Med Clin 95(16):618–620

14.

Hossain D, Weisberger J, Sreekantaiah C, Seiter K (1999) Biphenotypic (mixed myeloid/T-cell) extramedullary myeloid cell tumor. Leuk Lymphoma 33(3–4):399–402CrossRefPubMed

15.

Cervantes F, Anegon I, Rozman C, Gallart T, Pereira A, Vives-Corrons JL et al (1985) Early T-cell features in blast crisis of Ph1-positive chronic myeloid leukaemia. Scand J Haematol 35(1):71–76CrossRefPubMed

16.

Ganessan K, Goel R, Kumar K, Bakhshi S (2007) Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child. Pediatr Hematol Oncol 24(3):195–198CrossRefPubMed

17.

Chen X, Rutledge JC, Wu D, Fang M, Opheim KE, Xu M (2013) Chronic myelogenous leukemia presenting in blast phase with nodal, bilineal myeloid sarcoma and T-lymphoblastic lymphoma in a child. Pediatr Dev Pathol 16(2):91–96CrossRefPubMed

18.

Ye CC, Echeverri C, Anderson JE, Smith JL, Glassman A, Gulley ML et al (2002) T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumor. Hum Pathol 33(7):770–773CrossRefPubMed

19.

Kroschinsky F, Friedrich K, Hanel M, Mohr B, Langer T, Meinhardt M et al (2003) Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma. Ann Hematol 82(1):47–52PubMed

20.

Simpson E, O’Brien SG, Reilly JT (2006) Extramedullary blast crises in CML patients in complete hematological remission treated with imatinib mesylate. Clin Lab Haematol 28(3):215–216CrossRefPubMed

21.

Pullarkat ST, Vardiman JW, Slovak ML, Rao DS, Rao NP, Bedell V et al (2008) Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia. Leuk Res 32(11):1770–1775CrossRefPubMed

22.

Palatnik A, Narayan R, Walters M (2012) Extramedullary hematopoiesis involving uterus, fallopian tubes, and ovaries, mimicking bilateral tuboovarian abscesses. Int J Gynecol Pathol 31(6):584–587CrossRefPubMed

23.

Tsukamoto S, Ota S, Ohwada C, Takeda Y, Takeuchi M, Sakaida E et al (2013) Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation. Leuk Res Rep 2(2):67–69PubMedPubMedCentral

24.

Yu HH, Lu MY, Lin DT, Lin KH, Tang JL, Jou ST (2006) Pathological fracture as a manifestation of extramedullary blastic crisis in chronic myelogenous leukemia: report of one case. Acta Paediatr Taiwan 47(3):150–154PubMed

25.

Zeppa P, Marino G, Picardi M, Luciano L, Vetrani A, Palombini L (2002) Expression of NK-associated antigens in extramedullary lymph nodal blast crisis of chronic myeloid leukemia on fine-needle cytology. Diagn Cytopathol 27(3):158–160CrossRefPubMed

26.

Sakakura M, Ohishi K, Nomura K, Katayama N, Nishii K, Masuya M et al (2004) Case of chronic-phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin. Am J Hematol 77(2):167–170CrossRefPubMed

27.

Aleem A, Siddiqui N (2005) Chronic myeloid leukemia presenting with extramedullary disease as massive ascites responding to imatinib mesylate. Leuk Lymphoma 46(7):1097–1099CrossRefPubMed

28.

Al-Rayes HM, Al-Shaikh AA, Halim MA, Al-Qurashi FS, Al-Jurf MM (2001) Leukemic synovitis as a presentation of myelomonocytic blast crisis of chronic myeloid leukemia. Saudi Med J 22(9):808–811PubMed

29.

Beedassy A, Topolsky D, Styler M, Crilley P (2000) Extramedullary blast crisis in a patient with chronic myelogenous leukemia in complete cytogenetic and molecular remission on interferon-alpha therapy. Leuk Res 24(8):733–735CrossRefPubMed

30.

Faderl S, Talpaz M, Estrov Z, Kantarjian HM (1999) Chronic myelogenous leukemia: biology and therapy. Ann Intern Med 131(3):207–219CrossRefPubMed

31.

Hehlmann R (2012) How I treat CML blast crisis. Blood 120(4):737–747CrossRefPubMed

32.

Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C et al (2013) A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. N Engl J Med 369(19):1783–1796CrossRefPubMed

33.

Sacchi S, Kantarjian HM, O’Brien S, Cortes J, Rios MB, Giles FJ et al (1999) Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients. Cancer 86(12):2632–2641CrossRefPubMed

34.

Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F et al (2002) Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 99(6):1928–1937CrossRefPubMed

35.

Harada Y, Ishi K, Shirota T, Hayashi T (2000) New variant translocation (8;20)(q22;q13) in bone marrow cells of extramedullary blast crisis in chronic myelogenous leukemia. Cancer Genet Cytogenet 117(2):167–168CrossRefPubMed

36.

Okazuka K, Toba K, Kawai K, Nikkuni K, Tsuchiyama J, Momoi A et al (2001) Extramedullary T lymphoid blast crisis representing an additional translocation, t(6;8)(q25;q22) in a patient with Philadelphia-positive chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leuk Res 25(12):1089–1094CrossRefPubMed

37.

Gotoh A, Miyazawa K, Uchida Y, Sashida G, Kawakubo K, Kuriyama Y et al (2002) Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis. Int J Hematol 75(2):191–194CrossRefPubMed

38.

Naito K, Mori T, Miyazaki K, Tsukada Y, Ikeda Y, Okamoto S (2003) Successful treatment of extramedullary blast crisis of chronic myelogenous leukemia with imatinib mesylate (STI571). Intern Med 42(8):740–742CrossRefPubMed

39.

Madhumathi DS, Sundareshan TS, Amirtham U, Devi VL, Devi MG (2003) Blastic extramedullary myeloid cell tumor of the lymph node diagnosed by fine needle aspiration. Acta Cytol 47(1):101–103PubMed

40.

Breccia M, Nanni M, Mancini F, Russo E, Mecarocci S, Alimena G (2004) Extramedullary blast crisis occurring in a Philadelphia-positive chronic myeloid leukemia patient with major cytogenetic response to imatinib. Haematologica 89(4):ECR11

41.

Matsuda M, Morita Y, Shimada T, Miyatake J, Hirase C, Tanaka M et al (2005) Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate. Int J Hematol 81(4):307–309CrossRefPubMed

42.

Maloisel F, Favre G, Mahmal L, Zamfir A, Andres E (2005) Isolated lytic bone lesion as extramedullary disease in chronic myelogenous leukemia: a report of three new cases. Eur J Intern Med 16(4):288–290CrossRefPubMed

43.

Rajappa S, Uppin SG, Raghunadharao D, Rao IS, Surath A (2004) Isolated central nervous system blast crisis in chronic myeloid leukemia. Hematol Oncol 22(4):179–181CrossRefPubMed

44.

Tondon R, Singh PA, Misra V, Singh M, Mohan S (2005) Extramedullary blast crisis in chronic myeloid leukemia–a case report. Indian J Pathol Microbiol 48(2):253–254PubMed

45.

Chauhan S, Suri V, Varma S, Malhotra P, Varma N, Kaur A et al (2007) Granulocytic sarcoma: an unusual cause of compressive myelopathy. Am J Hematol 82(7):687–688CrossRefPubMed

46.

Kim AS, Goldstein SC, Luger S, Van Deerlin VM, Bagg A (2008) Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib? Am J Clin Pathol 129(4):639–648CrossRefPubMed

47.

Kobayashi Y, Tanaka T, Kawata E, Akaogi T (2011) Chronic myelogenous leukemia in the chronic phase with lymph node swelling which represented extramedullary involvement composed of cells at different stages of maturation. Rinsho Byori 59(4):360–363PubMed

48.

Shune L, Cayci Z, Rogosheske J, Brunstein C, Ustun C (2012) Extramedullary blastic crisis in abdominal lymph nodes in a patient with chronic myelogenous leukemia on imatinib. Leuk Res 36(6):e131–e132CrossRefPubMed

49.

Wei J, Huang M, Wang Y, Zhou J (2013) Sudden extramedullary blast crisis of chronic myeloid leukemia manifesting as T-cell lymphoblastic lymphoma. Onkologie 36(3):119–122CrossRefPubMed

50.

Jin GN, Zou P, Chen WX, Ding ZY, Zhou H (2013) Fluorescent in situ hybridization diagnosis of extramedullary nodal blast crisis. Diagn Cytopathol 41(3):253–256CrossRefPubMed

Title: Chronic Myeloid Leukemia with Extramedullary Blast Crisis: Two Unusual Sites with Review of Literature
Authors: Kamal Kant Sahu
Pankaj Malhotra
Preithy Uthamalingam
Gaurav Prakash
Amanjit Bal
Neelam Varma
Subhash Chandar Varma
Publication date: 01-06-2016
Publisher: Springer India
Published in: Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-014-0471-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2016

Dasatinib and Dysfunction of Platelets

Transfusion-Associated Graft-Versus-Host Disease with a Non-fatal Course

Priapism Associated with Homozygous Hb E State: A Causal Association or an Incidental Finding?

Secondary Sea-Blue Histiocytosis in a Patient with Transfusion Dependent HbE-Beta Thalassaemia and Osteosarcoma

Avascular Necrosis of Head of Femur in Dyskeratosis Congenita - A Rare Presentation

Rare Occurrence of 3 “H”: Hypercalcemia, Hemolytic Anemia and Hodgkin’s Lymphoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer